Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells

Journal of Pineal Research

Volumn 31, Issue 3, 2001, Pages 206-213

  Granzotto, Marilena ^a   Rapozzi, Valentina ^b   Decorti, Giuliana ^a   Giraldi, Tullio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Cytotoxicity; Doxorubicin; Melatonin; Multidrug resistance; Oncostatic action; Pleiotropic resistance

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; MELATONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; BREAST EPITHELIUM; CELL LEVEL; CELL STRAIN MCF 7; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLEIOTROPY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL DIVISION; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MELATONIN; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; TUMOR CELLS, CULTURED;

EID: 0034807909     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2001.310303.x     Document Type: Article

References (36)

1. Tissue distribution and disposition of daunomycin (NSC-82151) in mice: Fluorimetric and isotopic methods
2. A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
3. Physiological melatonin inhibition of human breast cancer cell growth in vitro: Evidence for a glutathione-mediated pathway
4. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events
5. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro
6. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin
7. Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture
8. Melatonin effects on intracellular junctional communication in MCF-7 human breast cancer cell
9. Melatonin, experimental basis for a possible application in breast cancer prevention and treatment
10. Melatonin and mammary pathological growth
11. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
12. Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer
13. Melatonin interactions with cultured murine B16 melanoma cells
14. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia
15. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines
16. Melatonin and the immune system
17. Effects of low-dose recombinant interleukin-2 in human malignancies
18. A phase II study of tamoxifen plus melatonin in metastatic solid turnout patients
19. Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
20. Melatonin plus interleukin-2 is more effective as neuroimmunotherapy than melatonin plus somatostatin analogs and bromocriptine as polyneuroendocrine therapy in untreatable advanced solid tumor patients
21. Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study
22. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status
23. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage-colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice
24. Antioxidative effect of melatonin in rat brain oxidative stress induced by adriamycin
25. Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats
26. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats
27. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
28. Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells
29. The oncostatic action of melatonin in an ovarian carcinoma cell line
30. Melatonin decreases bone marrow and lymphatic toxicity of Doxorubicin in mice bearing TLX5 lymphoma
31. Antioxidant actions of melatonin. Antioxidants in disease mechanisms and therapy
32. Aging and oxygen toxicity: Relation to changes in melatonin
33. Oxidative damage in the central nervous system: Protection by melatonin
34. Pharmacological actions of melatonin in oxygen radical pathophysiology
35. Multidrug resistance in oncology: Diagnostic and therapeutic approaches
36. Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice